Cargando…
Non-invasive assessment of liver fibrosis by serum metabolites in non-human primates and human patients
Liver fibrosis, a rising cause of chronic liver diseases, could eventually develop into cirrhosis and liver failure. Current diagnosis of liver fibrosis relies on pathological examination of hepatic tissues acquired from percutaneous biopsy, which may produce invasive injuries. Here, for non-invasiv...
Autores principales: | Feng, Tianhang, Lai, Chunyou, Yuan, Qiuyun, Yang, Wanchun, Yao, Yutong, Du, Mengze, Zhong, Deyuan, Wang, Sijia, Yang, Qinyan, Shang, Jin, Shi, Ying, Huang, Xiaolun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448158/ https://www.ncbi.nlm.nih.gov/pubmed/37636059 http://dx.doi.org/10.1016/j.isci.2023.107538 |
Ejemplares similares
-
ITGA5 and ITGB1 contribute to Sorafenib resistance by promoting vasculogenic mimicry formation in hepatocellular carcinoma
por: Shi, Ying, et al.
Publicado: (2022) -
Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma
por: Zhang, Zilong, et al.
Publicado: (2022) -
Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism
por: Zhang, Zilong, et al.
Publicado: (2023) -
Gynura segetum-induced liver injury leading to acute liver failure: a case report and literature review
por: Zhang, Zilong, et al.
Publicado: (2022) -
Prognostic value of inflammation‐immunity‐nutrition score in patients with hepatocellular carcinoma treated with anti‐PD‐1 therapy
por: Zhang, Zilong, et al.
Publicado: (2022)